CD42a antigen (GPIX) is a glycoprotein that forms a complex with non-covalently bound GPIb. This antigen is primarily expressed by platelets and megakaryocytes
| Inventor | Institute |
|---|---|
| Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol | Virgen de las Nieves University Hospital, The Andalusian Health Service |
| Cat. #: | 161691 |
|---|---|
| Tool sub type: | Primary antibody |
| Cancer types: | Blood cancer |
| Research Fields: | Cancer |
| Application: | FACS; IHC; ELISA; WB |
| Target: | GR-P |
| Reactivity: | Human |
| Clone: | GR-P |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Knapp et al. 1989. The Journal of Pathology. ISBN: 0192618679 |
| Product description: | CD42a antigen (GPIX) is a glycoprotein that forms a complex with non-covalently bound GPIb. This antigen is primarily expressed by platelets and megakaryocytes |
|---|---|
| Isotype: | IgG1 |
| Molecular weight: | 23 kDa |
| Immunogen: | B-ALL cells |
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Knapp et al. 1989. The Journal of Pathology. ISBN: 0192618679 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.